TrumpRx: President Donald Trump has struck new deals with nine major drug companies. These agreements aim to reduce prescription drug prices for Medicaid recipients and those paying out of pocket.

A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role ...

Indian pharmaceutical exports, including generic drugs, are unlikely to be affected by US President Donald Trump's recent announcement of 100 per cent tariffs on “any branded or patented" drugs ...

Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...

A federal judge in Pennsylvania has approved a nearly $60 million settlement with a trio of drug makers who are defendants in a multi-district litigation claiming numerous companies fixed the prices ...

Nov 12 (Reuters) - Plaintiffs in a sweeping antitrust case over generic drug pricing have asked a federal judge to intervene against a group of claims recovery firms they say are misleading class ...

Learn how an Abbreviated New Drug Application (ANDA) helps generic drugs get FDA approval without clinical trials, ensuring safety and bioequivalence with brand-name drugs.

Oct 31 (Reuters) - A federal judge on Friday said 36 drugmakers and executives must face nearly all claims in an antitrust lawsuit brought by most U.S. states, accusing them of conspiring to fix ...